๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Combined budesonide and antibiotic therapy for active Crohn's disease: A randomized controlled trial

โœ Scribed by Steinhart, A. Hillary (author);Feagan, Brian G. (author);Wong, Cindy J. (author);Vandervoort, Margaret (author);Mikolainis, Shelley (author);Croitoru, Kenneth (author);Seidman, Ernest (author);Leddin, Desmond J. (author);Bitton, Alain (author);Drouin, Eric (author);Cohen, Albert (author);Greenberg, Gordon R. (author)

Book ID
119756650
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
129 KB
Volume
123
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A randomized, double-blind, placebo-cont
A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease
โœ J. P. Wright; Dr. D. P. Jewell; R. Modigliani; H. Malchow ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 486 KB ๐Ÿ‘ 2 views

Olsalazine, consisting of two salicylate radicals linked by an azo-bond, is effective in the treatment of active ulcerative colitis. To test its effect in patients with mild to moderate attacks of Crohn's disease, the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) des